1. Therapeutic Potential of PARP Inhibitors in the Treatment of Gastrointestinal Cancers
   Abdullah Alhusaini et al, 2021, Biomedicines CrossRef
2. Targeted therapy for upper gastrointestinal tract cancer: current and future prospects
   Matthew W Rosenbaum et al, 2021, Histopathology CrossRef
3. High Poly(ADP-Ribose) Polymerase Expression Does Relate to Poor Survival in Solid Cancers: A Systematic Review and Meta-Analysis
   Nishant Thakur et al, 2021, Cancers CrossRef
4. Autophagy-Related Three-Gene Prognostic Signature for Predicting Survival in Esophageal Squamous Cell Carcinoma
   Heyang Cui et al, 2021, Frontiers in Oncology CrossRef
5. PARP Inhibitors Talazoparib and Niraparib Sensitize Melanoma Cells to Ionizing Radiation
   Stephanie Jonuscheit et al, 2021, Genes CrossRef
6. Targeting the SOX2/PARP1 complex to intervene in the growth of esophageal squamous cell carcinoma
   Zhuo Wang et al, 2022, Biomedicine & Pharmacotherapy CrossRef
7. A novel predicted ADP-ribosyltransferase-like family conserved in eukaryotic evolution
   Zbigniew Wyżewski et al, 2021, PeerJ CrossRef
8. Adenosine diphosphate–sensitive P2Y11 receptor inhibits endothelial cell proliferation by induction of cell cycle arrest in the S phase and induces the expression of inflammatory mediators
   Xiaobin Chen et al, 2019, Journal of Cellular Biochemistry CrossRef